{
    "Trade/Device Name(s)": [
        "VITEK 2 Streptococcus Trimethoprim / Sulfamethoxazole",
        "VITEK 2 AST-ST Trimethoprim / Sulfamethoxazole"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K113305",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063597"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "November 4, 2011",
    "Summary Letter Received Date": "November 9, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Trimethoprim",
        "Sulfamethoxazole"
    ],
    "Specimen Type(s)": [
        "Isolated colonies"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK 2",
        "VITEK 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Automated antimicrobial susceptibility testing",
        "Microdilution"
    ],
    "Methodologies": [
        "Minimum inhibitory concentration determination",
        "Qualitative susceptibility testing"
    ],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 AST-ST Trimethoprim / Sulfamethoxazole for antimicrobial susceptibility testing of Streptococcus species.",
    "Indications for Use Summary": "Aids in determining in vitro susceptibility of Streptococcus species, including S. pneumoniae, to Trimethoprim and Sulfamethoxazole using VITEK 2 and VITEK 2 Compact Systems.",
    "fda_folder": "Microbiology"
}